C. Baudet et al., DIFFERENTIALLY EXPRESSED GENES IN C6.9 GLIOMA-CELLS DURING VITAMIN-D-INDUCED CELL-DEATH PROGRAM, Cell death and differentiation, 5(1), 1998, pp. 116-125
C6.9 rat glioma cells undergo a cell death program when exposed to 1,2
5-dihydroxyvitamin D3 (1,25-D3). As a global analytical approach, we h
ave investigated gene expression in C6.9 engaged in this cell death pr
ogram using differential screening of a rat brain cDNA library with pr
obes derived from control and 1,25-D3-treated cells. Using this method
ology we report the isolation of 61 differentially expressed cDNAs. Fo
rty-seven cDNAs correspond to genes already characterized in rat cells
or tissues. Seven cDNAs are homologous to yeast, mouse or human genes
and seven are not related to known genes. Some of the characterized g
enes have been reported to be differentially expressed following induc
tion of programmed cell death. These include PMP22/gas3, MGP and beta-
tubulin. For the first time, we also show a cell death program induced
up-regulation of the c-myc associated primary response gene CRP, and
of the proteasome RN3 subunit and TCTP/mortalin genes. Another interes
ting feature of this 1,25-D3 induced-cell death program is the down re
gulated expression of transcripts for the microtubule motor dynein hea
vy chain/MAP 1C and of the calcium-binding S100 beta protein. Finally
15 upregulated cDNAs encode ribosomal proteins suggesting a possible i
nvolvement of the translational apparatus in this cell program. Altern
atively, these ribosomal protein genes could be up regulated in respon
se to altered rates of cellular metabolism, as has been demonstrated f
or most of the other isolated genes which encode proteins involved in
metabolic pathways. Thus, this study presents to our knowledge the fir
st characterization of genes which are differentially expressed during
a cell death program induced by 1,25-D3. Therefore, this data provide
s new information on the fundamental mechanisms which participate in t
he antineoplastic effects of 1,25-D3 and on the machinery of a cell de
ath program in a glioma cell line.